Shenzhen Baimuxing Technology Co.,Ltd. – Trademark Portfolio

Entity Type: 16

Shenzhen Baimuxing Technology Co.,Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 17 (Rubber Goods) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ARIFLOR and BELODYER. The owner is based in Shenzhen.

No. 1031,Fuqiang Road,Fumin Community

Futian Street,Futian District

Shenzhen 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ARIFLOR
ARIFLOR
Registered 2022
BELODYER
BELODYER
Registered 2021

Trademark Classifications

Shenzhen Baimuxing Technology Co.,Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

17
Rubber Goods (2 filings)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

Frequently Asked Questions

How many trademarks does Shenzhen Baimuxing Technology Co.,Ltd. have?

Shenzhen Baimuxing Technology Co.,Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhen Baimuxing Technology Co.,Ltd. file in?

Shenzhen Baimuxing Technology Co.,Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 17 (Rubber Goods). Class 17 covers unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica.

What are Shenzhen Baimuxing Technology Co.,Ltd.'s most well-known trademarks?

Shenzhen Baimuxing Technology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as ARIFLOR and BELODYER. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen Baimuxing Technology Co.,Ltd.'s trademark registration success rate?

Shenzhen Baimuxing Technology Co.,Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.